![Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases - ScienceDirect Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359644613004066-gr1.jpg)
Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases - ScienceDirect
![Effects of HDAC inhibitors in cancer cells. In healthy cells, promoters... | Download Scientific Diagram Effects of HDAC inhibitors in cancer cells. In healthy cells, promoters... | Download Scientific Diagram](https://www.researchgate.net/profile/Michael-Schnekenburger/publication/221826605/figure/fig2/AS:340317078343683@1458149322274/Effects-of-HDAC-inhibitors-in-cancer-cells-In-healthy-cells-promoters-of-TSGs-are_Q640.jpg)
Effects of HDAC inhibitors in cancer cells. In healthy cells, promoters... | Download Scientific Diagram
![Histone acetyltransferases: challenges in targeting bi-substrate enzymes | Clinical Epigenetics | Full Text Histone acetyltransferases: challenges in targeting bi-substrate enzymes | Clinical Epigenetics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13148-016-0225-2/MediaObjects/13148_2016_225_Fig1_HTML.gif)
Histone acetyltransferases: challenges in targeting bi-substrate enzymes | Clinical Epigenetics | Full Text
![Histone Acetyltransferases (HATs) Involved in Non-Homologous End Joining as a Target for Radiosensitization | IntechOpen Histone Acetyltransferases (HATs) Involved in Non-Homologous End Joining as a Target for Radiosensitization | IntechOpen](https://www.intechopen.com/media/chapter/45396/media/image1.jpeg)
Histone Acetyltransferases (HATs) Involved in Non-Homologous End Joining as a Target for Radiosensitization | IntechOpen
![Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines](https://www.spandidos-publications.com/article_images/ijo/51/6/IJO-51-06-1860-g00.jpg)
Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines
![The role of histone deacetylases (HDACs) in human cancer - Ropero - 2007 - Molecular Oncology - Wiley Online Library The role of histone deacetylases (HDACs) in human cancer - Ropero - 2007 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/8ddbad7a-5256-4eb9-845b-fcef22e2ed2e/mol220071119-fig-0001-m.jpg)
The role of histone deacetylases (HDACs) in human cancer - Ropero - 2007 - Molecular Oncology - Wiley Online Library
![Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/544683/fcell-08-00425-HTML-r2/image_m/fcell-08-00425-g001.jpg)
Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology
![A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy | Bentham Science A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cctr/15/2/004.jpg)
A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy | Bentham Science
![Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer | Future Oncology Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.11.2/asset/images/medium/figure2.gif)
Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer | Future Oncology
![HDAC and HAT activity toward DNA. HAT = histone acetyltransferase; HDAC... | Download Scientific Diagram HDAC and HAT activity toward DNA. HAT = histone acetyltransferase; HDAC... | Download Scientific Diagram](https://www.researchgate.net/publication/282446718/figure/fig2/AS:614123498909696@1523429860009/HDAC-and-HAT-activity-toward-DNA-HAT-histone-acetyltransferase-HDAC-histone.png)
HDAC and HAT activity toward DNA. HAT = histone acetyltransferase; HDAC... | Download Scientific Diagram
![Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-019-0095-0/MediaObjects/41392_2019_95_Fig1_HTML.png)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy
![Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed | Future Medicinal Chemistry Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.12.3/asset/images/medium/figure2.gif)
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed | Future Medicinal Chemistry
![Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells | Clinical Epigenetics | Full Text Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells | Clinical Epigenetics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13148-019-0800-4/MediaObjects/13148_2019_800_Figa_HTML.png)